Introduction
Most individuals with a diagnosis of schizophrenia will be confronted with some form of stigmatization.
1,2 Stigmatization refers to a stereotyped set of negative attitudes, incorrect beliefs, and fears about the diagnosis schizophrenia that impact on how this syndrome is actually understood by others. It involves problems of knowledge (ignorance), attitudes (prejudice), and behavior (discrimination) and may be compounded by a scientifically inaccurate emphasis on biogenetic models of illness on the part of professionals. [3] [4] [5] [6] Different types of stigmapublic stigma, self-stigma, and label avoidance 7 -may have profoundly defeating consequences for the individual with a psychotic disorder. [8] [9] [10] [11] Ritsher and Phelan 12 suggest that the harmful effects of stigma may work through the internal perceptions, beliefs, and emotions of the stigmatized person, even above and beyond the effects of direct discrimination by others. Most of the research in the area of stigma is based on negative reactions faced by people with schizophrenia in studies on public attitudes or equivalent behavioral research. Research exploring the views of those exposed to stigma is less common. Although stigma is typically noted in professional guidelines, possible interventions are not proposed. 13 Therefore, in the present article, the consequences of stigma and their potentially negative impact on onset, course, and outcome of schizophrenia are examined not only from a scientific but also from a user perspective.
Genetic Risk, Stigma, and Schizophrenia
Given the fact that the genetic vulnerability to schizophrenia is likely much more widely distributed than the illness itself, environmental factors impacting on vulnerable individuals may be invoked in order to explain the fact that not all vulnerable people make the transition to psychotic disorder.
14 What has received much less attention is the fact that some of these environmental factors may be provoked by the behavioral expression of genetic vulnerability itself, a phenomenon known as gene-environment correlation or rGE.
14 In some instances of rGE, the observed environmental risk factor merely represents a genetic epiphenomenon and is of no causal consequence itself. Sometimes, however, the environmental factor in rGE may still be of causal consequence. This latter scenario may be particularly relevant in the prodromal phase of the illness. According to the model described in this article and depicted in figure 1 , some of the causal environmental risks for schizophrenia in the realm of social adversity represent structural negative interpersonal interactions in response to the behavioral expression of genetic risk. For example, a person may become stigmatized on the basis of odd speech or paranoid reactions that are the expression of schizophrenia liability. Although in this case stigmatization does not occur on the basis of a formal diagnosis, structural discrimination may nevertheless occur if the behavior is perceived, similar to schizophrenia, as different, out of the ordinary or strange. To the degree that stigma is a form of structural discrimination, the term may be of use in highlighting these early processes associated with schizophrenia liability and form a continuum with the stigma observed after illness onset and its negative consequences on illness course (figure 1). The central theme is that stigmatization/structural discrimination can be perceived as a component of social adversity, which can lead to social defeat and shape specific negative beliefs about the self and about others. 15 Presenting the negative interactions induced by liability and illness and their impact on, respectively, onset and course in 1 model may help focus attention on these issues and create more research culminating in risk-reducing strategies.
Stigma and Onset of Schizophrenia
Schizophrenia and other psychotic disorders are characterized by alterations in behavioral and cognitive development and, closer to the onset of the first psychotic episode, by an at-risk mental state or ''prodromal'' phase of illness in which a noticeable change from premorbid functioning occurs. 16 Different types of prodrome have been identified, and patients may progress from 1 type to another. 17 For example, in 1 type, psychotic symptoms may appear intermittently but briefly. Subsequently, subclinical psychotic symptoms may persist for longer periods, and individuals may at some stage meet International Classification of Diseases, Tenth Revision, criteria for schizotypal personality disorder. Another type consists of neurotic symptoms, which commonly start before positive symptoms; individuals may meet criteria for depression or anxiety disorders. 17 The question rises to what degree subtle negative interpersonal interactions induced by the changing behavior of individuals with an at-risk mental state may contribute to the risk of transition to a psychotic disorder. In other words, is it possible that subclinical psychotic experiences or other behavioral expressions of risk provoke stigmatizing reactions that further fuel the underlying psychotic process, increasing the risk for transition to a clinical psychotic episode?
There is face validity to the notion that people displaying behavioral expression of schizophrenia liability, whether it be in the form of a ''prodrome,'' in the context of ''schizotypal'' low-grade psychotic experiences or even in the form of subtle developmental behavioral alterations long before illness onset, 18 are likely to experience structural discrimination/stigmatization to a degree that it becomes relevant in terms of altering risk for transition to psychotic disorder. Although research is needed to address this question before firm conclusions can be drawn and interventions can be developed or adjusted, there is nevertheless some support for this notion in the literature. For example, Janssen et al 19 examined whether perceived discrimination on the basis of skin color or ethnicity, gender, age, appearance, disability, or sexual orientation was prospectively associated with onset of psychotic symptoms. The results indicated that perceived discrimination predicted, in a dose-response fashion, incident delusional ideation. One way of explaining these findings is to hypothesize that subtle changes in the behavior of individuals with early expression of psychosis liability give rise to negative social interactions and structural discrimination that in turn increase the risk for delusional ideation, eg, by facilitating a paranoid attributional style 20 and/or by sensitization (and/or increased baseline activity) of the mesolimbic dopamine system. 21 A prediction from this model is that in populations who suffer structural discrimination, the proportion of individuals with vulnerability for schizophrenia that actually makes the transition to psychotic disorder should be higher than in nonstigmatized populations. Recent work showing that the observed increased risk for schizophrenia in ethnic minority groups is contingent on the level of associated discrimination these groups are facing is compatible with this notion. 22 
Stigma and Illness Course

Course and Outcome
Although traditional follow-up studies of cohorts of patients to date have not included measures of stigma as a course modifier, there are nevertheless several reasons to assume that a strong association likely exists. Stigmatization may lead to negative discrimination, which in turn leads to numerous disadvantages in access to care, poor health service, and frequent life events that can damage self-esteem. 23 Stigmatization represents a chronic stressor and therefore, given evidence that stress triggers episodes of schizophrenia, 24, 25 may act as a modifier of illness course. For example, there is some evidence that social stressors such as stigmatizing interactions and victimization can exacerbate symptoms and impact on social functioning. 26, 27 Furthermore, stigmatization, in the sense of label avoidance, can cause a delay in helpor treatment-seeking behavior. In particular, the threat of social disapproval or diminished self-esteem that accompanies the label may account for underuse of services. 28 In addition, prejudice and discrimination related to schizophrenia have been observed to result in poor treatment compliance. 29 In a study about internalized stigma, Ritsher and Phelan 12 found that alienation predicted depressive symptoms and reduced self-esteem, suggesting that it may be very difficult for individuals to escape, without assistance, a vicious circle of low self-esteem and alienation negatively impacting on each other. 12 Awareness of illness may result in better functional outcome, but if awareness is accompanied by acceptance of stigmatizing beliefs, greater social dysfunction, less hope, and lower self-esteem become more likely. 30 
Psychopathology and Quality of Life
Stigma leads to negative psychological outcomes among the mentally ill, including lowered self-esteem, 12,31 diminished self-efficacy, 31 and more depressive symptoms. 12, 31 In a qualitative study by Dinos et al, 9 the most common consequences of feelings of stigma revolved around anger, depression, fear, anxiety, feelings of isolation, guilt, embarrassment, and prevention from recovery or avoidance of help seeking. Around 1 in 3 patients with a diagnosis of schizophrenia has a social anxiety disorder, and it has been suggested that stigma may be closely related to social anxiety in schizophrenia. Thus, presence of social anxiety was predicted by greater experience of shame related to the psychotic diagnosis. 32 This finding is highly relevant, given that higher levels of anxiety are associated with more hallucinations, withdrawal, depression, hopelessness, better insight, and poorer function and outcome. 33, 34 Finally, there is evidence that prejudice and discrimination related to schizophrenia result in an increased probability of misuse of alcohol and drugs. 29 Stigmatization can have detrimental consequences for both objective and subjective quality of life (QOL). Attributing one's problems to a mental illness is associated with reduced subjective QOL among persons with schizophrenia, much of which may be mediated by perceived stigma and lower self-esteem. 35, 36 Persons with mental health problems are often socially rejected, which can have negative consequences for their well-being in general and their self-esteem in particular. 37 Anxiety disorders may impose an additional burden to patients with schizophrenia, resulting in further decline in their subjective QOL. 38 
Interventions for Modifiable Risks?
The data discussed above suggest that stigma may be seen in part as a modifiable risk factor for onset and persistence of psychosis; individual treatments may be developed to promote resilience and help individuals cope better. These interventions may not only be relevant for coping with stigma after illness onset but also before, if individuals show subtle alterations in behavior associated with schizophrenia liability. Although such interventions remain to be developed, the literature suggests a few simple guidelines that may be generally applicable. First, it is useful to differentiate between negative symptoms, depression, anxiety, and the consequences of stigmatization. For example, social isolation can be the result of all the above. Knowledge about (the consequences of) stigmatization is essential in understanding the coping strategies people with schizophrenia or other psychotic disorders apply. Conveying such knowledge to professionals during training and to patients and relatives during psychoeducation would be a useful first step. 39 Second, several studies have shown that the negative impact of stigma is greater if individuals use avoidant and isolating coping styles in the face of stigma. 11, [40] [41] [42] [43] [44] This suggests that induction of more active coping styles and sharing of experiences, possibly in the context of peer support, 45 may be the ingredients of tailored treatments. Another important way of approaching stigma reduction is to offer ways of integration and recovery, eg, through paid employment, which has been observed to reduce stigma. 46 
